145 related articles for article (PubMed ID: 373006)
1. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
Schooler NR; Levine J; Severe JB
Psychopharmacol Bull; 1979 Apr; 15(2):44-7. PubMed ID: 373006
[No Abstract] [Full Text] [Related]
2. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
[No Abstract] [Full Text] [Related]
3. [Experience with depot neuroleptics].
Arató M; Erdós A
Orv Hetil; 1979 Apr; 120(17):1015-21. PubMed ID: 372888
[No Abstract] [Full Text] [Related]
4. Dosage and side effect comparisons betweel oral and depot fluphenazine.
Schooler NR; Levine J
Psychopharmacol Bull; 1977 Jul; 13(3):29-31. PubMed ID: 329328
[No Abstract] [Full Text] [Related]
5. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
Faltus F
Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
[No Abstract] [Full Text] [Related]
6. Long-acting phenothiazines for treatment of schizophrenia.
Med Lett Drugs Ther; 1976 Jan; 18(2):6-7. PubMed ID: 1107791
[No Abstract] [Full Text] [Related]
7. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
[No Abstract] [Full Text] [Related]
8. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
Friemert K; Beier R; Vehreschild T
Psychiatr Neurol Med Psychol (Leipz); 1974 Jun; 26(6):374-7. PubMed ID: 4849639
[No Abstract] [Full Text] [Related]
9. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
[No Abstract] [Full Text] [Related]
10. The use of depot neuroleptics: clinical experience in the United States.
Kane JM
J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of relapse in the era of depot neuroleptics and social psychiatry].
Schindler R
Nervenarzt; 1976 May; 47(5):347-50. PubMed ID: 179025
[No Abstract] [Full Text] [Related]
12. A pilot study of "low-dose" fluphenazine decanoate in outpatient schizophrenics [proceedings].
Kane J; Rifkin A; Quitkin F
Psychopharmacol Bull; 1979 Apr; 15(2):78-80. PubMed ID: 373007
[No Abstract] [Full Text] [Related]
13. Our experience with Moditene-Depot in chronic schizophrenia.
Gamkrelidze ShA; Putkoradze-Gamkrelidze NA
Act Nerv Super (Praha); 1973 Aug; 15(3):169. PubMed ID: 4769133
[No Abstract] [Full Text] [Related]
14. [Personal experience with prolonged-action fluphenazine].
Król K; Krystof J
Psychiatr Pol; 1974; 8(2):149-55. PubMed ID: 4830322
[No Abstract] [Full Text] [Related]
15. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
Schooler NR; Levine J
Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
[TBL] [Abstract][Full Text] [Related]
16. [Depot fluphenazine as a means of stabilizing remission in cases of schizophrenia].
Vovin RIa; Vovina EN
Psychiatr Neurol Med Psychol Beih; 1975; 20-21():183-7. PubMed ID: 829620
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
18. [Effect of moditen-depot therapy on the duration and quality of remissions in schizophrenia patients].
Vovin RIa; Gurovich IIa; Eryshev OF; Zaĭtsev SG; Magalif AIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(5):743-9. PubMed ID: 899478
[TBL] [Abstract][Full Text] [Related]
19. [Long-term therapy with depot-fluphenazine Dapotum in schizophrenia].
Moldenhauer B
Med Welt; 1966 Jul; 27():1477-81. PubMed ID: 5985539
[No Abstract] [Full Text] [Related]
20. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
Rifkin A; Quitkin F; Kane J; Klein DF
Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
